Pitfalls in the Histological Diagnosis of Morphologic Variants of Invasive Lobular Carcinoma of the Breast
Modern Pathology · 2025
DOI: 10.1016/j.modpat.2025.100837 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Modern Pathology, 2025. Verfasst von Giuseppe Floris und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Imaging and Pathology, Laboratory for translational Cell and Tissue Research, KU Leuven, Leuven, Belgium; Department of Pathology, Univ…. Hauptthemen laut MEDLINE: Carcinoma, Lobular, Breast Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Fonds Wetenschappelijk Onderzoek, National Cancer Institute.
Abstract (Originalsprache)
Invasive lobular carcinoma (ILC) is the second most frequent histological type of breast cancer and the most frequent special type. Disruption of cell-to-cell adhesion, caused most often by E-cadherin loss of function, results in the distinctive histomorphology of ILC, which is characterized by single threads of monotonous, dyscohesive neoplastic epithelial cells infiltrating the breast parenchyma with little or no stromal reaction, referred to as classic ILC. In the past 4 decades, ILC variants that differ from classic ILC with regard to architectural, cytological, and/or nuclear features have been described. The recognition and correct characterization of ILC, including its variant forms, is essential to avoid misdiagnosis and its possible treatment implications. Some ILC variants may be associated with more aggressive clinical behavior compared with classic ILC, independent of standard predictive and prognostic parameters. Additionally, the distinctive biological and clinical features of ILC are increasingly being investigated as therapeutic targets in ILC-tailored clinical trials. In this manuscript, we have undertaken an in-depth review of the current state of knowledge about ILC variants. Evidence gained from molecular analysis of ILC and its microenvironment suggests that ILC variants are biologically distinct from classic ILC. However, this conclusion is undermined by the imprecise histopathological identification of ILC variants. In the absence of standardized and simplified criteria for the diagnosis of ILC, underrecognition of ILC variants may translate into missed opportunities for tailored treatment of ILC patients. Therefore, we propose steps toward the development of a roadmap that will ultimately lead to a more reproducible classification of ILC variants and improve our knowledge of these challenging tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Imaging and Pathology, Laboratory for translational Cell and Tissue Research, KU Leuven, Leuven, Belgium; Department of Pathology, University Hospitals Leuven, KU Leuven, Leuven, Belgium. Electronic addres…
- Department of Diagnostic and Theranostic Medicine, Institut Curie, Institut des Cancers des Femmes, Université Paris Sciences Lettres, Paris, France; Department of Pathology, Institut Curie, Institut des Cancers des Fem…
- Department of Imaging and Pathology, Laboratory for translational Cell and Tissue Research, KU Leuven, Leuven, Belgium; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Bel…
- Department of Pathology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
- Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
- Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Förderung
- NCI NIH HHS
- Fonds Wetenschappelijk Onderzoek
- National Cancer Institute
- National Institutes of Health
- National Institute of Nursing Research
Zitieren
APA
Floris, G., Djerroudi, L., Zels, G., De Schepper, M., Richard, F., Brahimaj, R., Derksen, P. W. B., Christgen, M., Lakhani, S. R., Van Diest, P. J., Brogi, E., Desmedt, C., Schnitt, S. J., Vincent-Salomon, A., & European Lobular Breast Cancer Consortium (2025). Pitfalls in the Histological Diagnosis of Morphologic Variants of Invasive Lobular Carcinoma of the Breast. Modern Pathology. https://doi.org/10.1016/j.modpat.2025.100837
Vancouver
Floris G, Djerroudi L, Zels G, De Schepper M, Richard F, Brahimaj R, et al. Pitfalls in the Histological Diagnosis of Morphologic Variants of Invasive Lobular Carcinoma of the Breast. Modern Pathology. 2025. doi:10.1016/j.modpat.2025.100837
BibTeX
@article{Floris2025,
author = {Floris, Giuseppe and Djerroudi, Lounes and Zels, Gitte and De Schepper, Maxim and Richard, François and Brahimaj, Rigleta and Derksen, Patrick W B and Christgen, Matthias and Lakhani, Sunil R and Van Diest, Paul J and Brogi, Edi and Desmedt, Christine and Schnitt, Stuart J and Vincent-Salomon, Anne and European Lobular Breast Cancer Consortium, European Lobular Breast Cancer Consortium},
title = {Pitfalls in the Histological Diagnosis of Morphologic Variants of Invasive Lobular Carcinoma of the Breast},
journal = {Modern Pathology},
year = {2025},
doi = {10.1016/j.modpat.2025.100837}
}
EUVIMED